SHAWN MCGOWAN: Open Payments
NPI 1114927654 · ELLSWORTH, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$852 in 55 payments from 14 companies in 2025. Trend: 2023 $965 · 2024 $735 · 2025 $852
Food & beverage: $852
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $269 |
| PFIZER INC. | 11 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $94 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
| Sumitomo Pharma America, Inc. | 3 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Novo Nordisk Inc | 2 | $31 |
| Amgen Inc. | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
Products named: VRAYLAR, NURTEC ODT, CAPLYTA, LEQVIO, GEMTESA, QULIPTA, PREVNAR 20, XIFAXAN.
Industry payments across KS — which companies pay providers there.
